The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Desperation In India As COVID-19 Rages – Critics Take To Social Media, While Vaccine Manufacturers Hike Prices 26/04/2021 Disha Shetty PUNE – Indian twitter for days has been a desperate space. There are appeals for oxygen cylinders, cries for funding to meet healthcare costs, and panic-stricken relatives scouting for hospital beds for their loved ones. Hospitals are now approaching the courts for help as they run out of oxygen. And even prominent lawyers and influencers […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> As COVID-19 Cases Climb Globally For 8th Week In Row – Only 1% Of Vaccines Administered Were in Low Income Countries 19/04/2021 Elaine Ruth Fletcher New COVID-19 cases climbed again globally last week for the eighth week in a row – while only 1% of the 100 million vaccine doses administered last week were in low- and middle-income countries – said senior WHO officials on Monday, citing two key barometers of pandemic policies. Meanwhile, speaking at a WHO press conference […] Continue reading -> Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
Desperation In India As COVID-19 Rages – Critics Take To Social Media, While Vaccine Manufacturers Hike Prices 26/04/2021 Disha Shetty PUNE – Indian twitter for days has been a desperate space. There are appeals for oxygen cylinders, cries for funding to meet healthcare costs, and panic-stricken relatives scouting for hospital beds for their loved ones. Hospitals are now approaching the courts for help as they run out of oxygen. And even prominent lawyers and influencers […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> As COVID-19 Cases Climb Globally For 8th Week In Row – Only 1% Of Vaccines Administered Were in Low Income Countries 19/04/2021 Elaine Ruth Fletcher New COVID-19 cases climbed again globally last week for the eighth week in a row – while only 1% of the 100 million vaccine doses administered last week were in low- and middle-income countries – said senior WHO officials on Monday, citing two key barometers of pandemic policies. Meanwhile, speaking at a WHO press conference […] Continue reading -> Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> As COVID-19 Cases Climb Globally For 8th Week In Row – Only 1% Of Vaccines Administered Were in Low Income Countries 19/04/2021 Elaine Ruth Fletcher New COVID-19 cases climbed again globally last week for the eighth week in a row – while only 1% of the 100 million vaccine doses administered last week were in low- and middle-income countries – said senior WHO officials on Monday, citing two key barometers of pandemic policies. Meanwhile, speaking at a WHO press conference […] Continue reading -> Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> As COVID-19 Cases Climb Globally For 8th Week In Row – Only 1% Of Vaccines Administered Were in Low Income Countries 19/04/2021 Elaine Ruth Fletcher New COVID-19 cases climbed again globally last week for the eighth week in a row – while only 1% of the 100 million vaccine doses administered last week were in low- and middle-income countries – said senior WHO officials on Monday, citing two key barometers of pandemic policies. Meanwhile, speaking at a WHO press conference […] Continue reading -> Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> As COVID-19 Cases Climb Globally For 8th Week In Row – Only 1% Of Vaccines Administered Were in Low Income Countries 19/04/2021 Elaine Ruth Fletcher New COVID-19 cases climbed again globally last week for the eighth week in a row – while only 1% of the 100 million vaccine doses administered last week were in low- and middle-income countries – said senior WHO officials on Monday, citing two key barometers of pandemic policies. Meanwhile, speaking at a WHO press conference […] Continue reading -> Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
As COVID-19 Cases Climb Globally For 8th Week In Row – Only 1% Of Vaccines Administered Were in Low Income Countries 19/04/2021 Elaine Ruth Fletcher New COVID-19 cases climbed again globally last week for the eighth week in a row – while only 1% of the 100 million vaccine doses administered last week were in low- and middle-income countries – said senior WHO officials on Monday, citing two key barometers of pandemic policies. Meanwhile, speaking at a WHO press conference […] Continue reading -> Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts